Fortune Capital
VC Fund
Coral Gables, United States
Fortune Capital is a financial firm that concentrates on property transactions and investing.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 49%
Last updated:
For AI agents: llms.txt
Industries Fortune Capital invests in
Stages Fortune Capital invests in
Countries Fortune Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Series A
- $3M–$43M
- Series B
- $14M–$31M
- Series C
- $100M–$563M
Investment Focus
Industry
- Health Care 10 (24%)
- Artificial Intelligence 6 (15%)
- Information Technology 5 (12%)
- Medical 4 (10%)
- Hardware 4 (10%)
Stage
- Series A 20 (49%)
- Series B 7 (17%)
- Series C 4 (10%)
- Seed 3 (7%)
- Series D 3 (7%)
Country
- China 36 (88%)
- Hong Kong 1 (2%)
- United States 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
| CFO | Total investments: 0 | Find email | ||
|
Joseph Poyastro
Associate
|
Associate | Total investments: 0 | Find email | |
Miguel Poyastro
President / CEO
|
President / CEO | Total investments: 0 | Find email | |
|
Seth Heller
Managing Director
|
Managing Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
VAST
|
VAST is an artificial intelligence business that develops and manufactures general-purpose 3D big models. Its goal is to develop a popular 3D content production tool, a 3D user-generated content platform, and utilize 3D space to enhance user experience. | Seed / Sep 19, 2024 | |
Atom Bioscience & Pharmaceutical
|
Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis. | $82.1M / Series D / Oct 16, 2023 | |
Jinsheng New Energy
|
Jinsheng New Energy is a lithium battery recycling solution provider. | Series B / Nov 03, 2022 | |
SiBionics
|
SiBionics is a medtech specialized in R&D & commercialization of implantable medical devices and medical imaging artificial intelligence. | $126M / Series C / Jan 21, 2022 | |
METiS Pharmaceuticals
|
METiS Pharmaceuticals is the world's first AI-driven drug formulation company. | $86M / Series A / Dec 13, 2021 | |
Natural Melody
|
Natural Melody is a cosmetics brand that offers skin-care products. | $31.3M / Series B / Oct 28, 2021 | |
Dreame Technology
|
Dreame Technology produces premium hairdryers and vacuums in the style of Dyson. | $563.1M / Series C / Oct 21, 2021 | |
OSUGA
|
Osuga is a sexual wellness brand. | $38.7M / Series A / Sep 08, 2021 | |
Gene+
|
Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention, early detection, as well as providing data for the implementation of precision medicine. The company claims to operate in around 100 hospitals and have served thousands of cancer patients in China. | $115.9M / Series C / Jul 22, 2021 | |
Zonsen Peplib Biotech
|
Zonsen aims to build up a super-sized peptide compound library and provide peptide drug discovery and development services. | $34M / Series A / Apr 30, 2021 | |
| See all 41 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Fortune Capital invest in?
Fortune Capital invests primarily in Health Care, Artificial Intelligence and Information Technology startups, most often at Series A and Series B stage. Most of the 41 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Fortune Capital's check size?
Fortune Capital typically joins rounds of $3M–$43M at Series A, $14M–$31M at Series B and $100M–$563M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Fortune Capital participates in.
How do I contact Fortune Capital?
Public channels for Fortune Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Fortune Capital?
The team at Fortune Capital includes Barbara Belkis Perez (CFO), Joseph Poyastro (Associate) and Miguel Poyastro (President / CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
